DƯỢC LÍ Goodman & Gilman's The Pharmacological Basis of Therapeutics 12th, 2010

Sanders-Bush E, Airey DC. Centennial perspective: serotonin
receptors. Mol Interv, 2008, 8:200–203.
Sanders-Bush E, Fentress H, Hazelwood L. Serotonin 5-HT 2
receptors: Molecular and genomic diversity. Mol Interv, 2003,
3:319–330.
Saudou F, Amara DA, Dierich A, et al. Enhanced aggressive
behavior in mice lacking 5-HT1B receptor. Science, 1994,
265:1875–1878.
Schetz JA. Allosteric modulation of dopamine receptors. Mini
Rev Med Chem, 2005, 5:555–561.
Sibley DR. New insights into dopaminergic receptor function
using antisense and genetically altered animals. Annu Rev
Pharmacol Toxicol, 1999, 39:313–341.
Silberstein SD. Treatment recommendations for migraine. Nat
Clin Pract Neurol, 2008, 4:482–489.
Steiner JA, Carneiro AM, Blakely RD. Going with the flow:
Trafficking-dependent and -independent regulation of serotonin
transport. Traffic, 2008, 9:1393–1402.
Strange PG. Agonism and inverse agonism at dopamine D2-like
receptors. Clin Exp Pharmacol Physiol Suppl, 1999,
26:S3–S9.
Swerdlow NR, Braff DL, Geyer MA. Animal models of deficient
sensorimotor gating: what we know, what we think we know,
and what we hope to know soon. Behav Pharmacol, 2000,
11:185–204.
Tecott LH, Sun LM, Akana SF, et al. Eating disorder and
epilepsy in mice lacking 5-HT 2C
serotonin receptors. Nature,
1995, 374:542–546.
Urban JD, Clarke WP, von Zastrow M, et al. Functional selectivity
and classical concepts of quantitative pharmacology.
J Pharmacol Exp Ther, 2007, 320:1–13.
Usiello A, Baik JH, Rouge-Pont F, et al. Distinct functions of the two
isoforms of dopamine D2 receptors. Nature, 2000, 408:199–203.
Van Tol HH, Wu CM, Guan HC, et al. Multiple dopamine D4
receptor variants in the human population. Nature, 1992,
358:149–152.
Van Tol HH, Wu CM, Guan HC, et al. Multiple dopamine D 4
receptor variants in the human population. Nature, 1992,
358:149–152.
Walther DJ, Bader M. A unique central tryptophan hydroxylase
isoform. Biochem Pharmacol, 2003, 66:1673–1680.
Walther DJ, Bader M. A unique central tryptophan hydroxlyase
isoform. Biochem Pharmacol, 2003, 66:1673–1680.
Weisstaub NV, Zhou M, Lira A, et al. Cortical 5-HT2A receptor
signaling modulates anxiety-like behaviors in mice. Science,
2006, 313:536–540.
Williams GV, Castner SA. Under the curve: critical issues for
elucidating D1 receptor function in working memory.
Neuroscience, 2006, 139:263–276.
Winter JC. Hallucinogens as discriminative stimuli in animals:
LSD, phenethylamines, and tryptamines. Psychopharmacology
(Berl), 2009, 203:251–263.
Woolley ML, Waters KA, Reavill C, et al. Selective dopamine
D4 receptor agonist (A-412997) improves cognitive performance
and stimulates motor activity without influencing rewardrelated
behaviour in rat. Behav Pharmacol, 2008, 19:765–776.
Zeitz KP, Guy N, Malmberg AB, et al. The 5-HT 3
subtype of
serotonin receptor contributes to nociceptive processing via a
novel subset of myelinated and unmyelinated nociceptors. J
Neurosci, 2002, 22:1010–1019.
361
CHAPTER 13
5-HYDROXYTRYPTAMINE (SEROTONIN) AND DOPAMINE